Related Experiment Video

Updated: May 29, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

[Problem of influenza prophylaxis by vaccines]

Iu Z Gendon, Iu M Vasiliev

    Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
    |September 15, 2011
    PubMed

    Insights

    Influenza prophylaxis is crucial across all age groups, with mass childhood vaccination being the most effective strategy for widespread protection and reduced economic impact.

    Area of Science:

    • Virology
    • Immunology
    • Public Health

    Context:

    • Influenza poses significant health and economic challenges globally.
    • Effective prophylaxis strategies are essential to mitigate influenza's impact across diverse populations.

    Purpose:

    • To discuss challenges and propose optimal strategies for influenza prophylaxis in various age demographics.
    • To highlight the importance of vaccination for different age groups, including pregnant women, children, adults, and the elderly.

    Summary:

    • Influenza prophylaxis in neonates can be achieved through maternal antibodies, necessitating vaccination during pregnancy.
    • Children aged 6 months to 2 years require more effective, well-tolerated vaccines.
    • Prophylaxis in working adults is key to reducing economic losses during epidemics.
    • Elderly individuals benefit from novel, adjuvant-enhanced vaccines.
    • Mass vaccination of children (80%) is identified as the optimal general population strategy, potentially reducing overall influenza morbidity by up to 80%.

    Impact:

    • Implementing targeted influenza prophylaxis strategies can significantly reduce disease burden.
    • Mass childhood vaccination offers a highly effective approach to achieving herd immunity and protecting vulnerable populations.
    • Economic losses due to influenza epidemics can be substantially minimized through effective prevention.

    More Related Videos

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    Expression and Purification of Virus-like Particles for Vaccination06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...